Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A).
Hirano H, Kataoka K, Yamaguchi T, Wagner AD, Shimada Y, Inomata M, Hamaguchi T, Takii Y, Mizusawa J, Sano Y, Shiomi A, Shiozawa M, Ohue M, Adachi T, Ueno H, Ikeda S, Komori K, Tsukamoto S, Takashima A, Kanemitsu Y.
Hirano H, et al. Among authors: sano y.
Eur J Cancer. 2024 Nov 19;214:115139. doi: 10.1016/j.ejca.2024.115139. Online ahead of print.
Eur J Cancer. 2024.
PMID: 39579641